FIGURE 1.
Primary and secondary outcomes in patients with type 2 diabetes discharged on liraglutide and insulin glargine. A, glycated haemoglobin (HbA1c) at baseline, 12 weeks, and 26 weeks. B, Change in body weight from baseline. C, HbA1c < 7% (53 mmol/mol) and no hypoglycaemia or weight loss. D, HbA1c < 7% (53 mmol/mol) and no hypoglycaemia